Mak Robert H, Kuo Huey-Ju
Division of Pediatric Nephrology, Oregon Health & Science University, Portland, Oregon 97239, USA.
Curr Opin Pediatr. 2006 Apr;18(2):148-52. doi: 10.1097/01.mop.0000193276.39495.0d.
Urinary tract infection is the second most common bacterial infection in children. It may cause renal scarring leading to secondary hypertension and chronic kidney disease. Recent information has greatly improved our understanding of the pathogenesis of urinary tract infection and renal scarring.
Urothelium, an anatomical barrier for innate immune responses, expresses toll-like receptors with the capacity to recognize pathogen-associated molecular patterns. Engagement of toll-like receptors can lead to uroepithelial cell activation and production of inflammatory mediators. These include complement proteins, other bactericidal peptides, cytokines, chemokines, defensins and adhesion molecules. The resulting inflammatory infiltrate serves to aid bacterial clearance but can also lead to renal damage. Furthermore, interactions between urinary proteins, such as Tamm-Horsfall protein, and TLR-4 add to the complexity of this defense system. Interindividual variability in cellular response may in part be responsible for variable clinical outcomes. Polymorphisms in a number of candidate genes in this host defense mechanism may be involved in determining those patients who are susceptible to recurrent infections and renal scarring following urinary tract infection.
Further understanding of the basic molecular mechanisms of urinary tract infection and translating these bench data to the bedside holds the promise of improving diagnosis and therapeutic strategies of treating urinary tract infection and preventing recurrence and renal scarring.
尿路感染是儿童第二常见的细菌感染。它可能导致肾瘢痕形成,进而引发继发性高血压和慢性肾病。近期的信息极大地增进了我们对尿路感染和肾瘢痕形成发病机制的理解。
尿路上皮作为先天性免疫反应的解剖屏障,表达具有识别病原体相关分子模式能力的Toll样受体。Toll样受体的激活可导致尿路上皮细胞活化并产生炎症介质。这些介质包括补体蛋白、其他杀菌肽、细胞因子、趋化因子、防御素和黏附分子。由此产生的炎症浸润有助于细菌清除,但也可能导致肾损伤。此外,尿蛋白(如Tamm-Horsfall蛋白)与TLR-4之间的相互作用增加了这种防御系统的复杂性。个体细胞反应的差异可能部分导致了不同的临床结果。宿主防御机制中多个候选基因的多态性可能参与决定哪些患者易发生复发性感染以及尿路感染后肾瘢痕形成。
进一步了解尿路感染的基本分子机制,并将这些实验室数据应用于临床,有望改善尿路感染的诊断和治疗策略,预防复发和肾瘢痕形成。